FORGIVE THE CAPS....SOME VERY ILL PEOPLE CAN READ BETTER IN CAPS...FIRST...
IGENEX... ..
LYME IMMUNOBLOTS, TICK BORNE RELAPSING FEVER ANTIBODIES, ALL BABESIA ANTIBODIES, ERHLICHIA ANTIBODIES, ANAPLASMA ANTIBODIES, ALL BARTONELLA ANTIBODIES...,
GALAXY DIAGNOSTICS...BARTONELLA ANTIBODIES, LYME ANTIBODIES, THREE ENRICHED MEDIA SPECIAL PCR ON THREE DIFFERENT DAYS IF HIGHLY MOTIVATED. CONTACT TO DISCUSS THEIR CUTTING EDGE THREE PCR FEATURES. ...NEXT......
DNA CONNECTIONS URINE TESTING. I
INFECTO LABS TEST 3056 OR THE SCHALLER PANEL AT ENGLAND INFECTO SERVING ALL EUROPE... MAYBE
IMMUNOSCIENCES...,
RED LAB--PHAGE--BELGIUM...
ARMIN LABS IN GERMANY
VIBRANT? NO FIRM OPINION. THEY DO NOT REPLY TO PHYSICIAN QUESTIONS AND I AMNOT AWARE OF ANY PEER-REVIEWED RESEARCH BY THE LAB SCIENTISTS....
I ALSO GET ABOUT 80 TESTS OVER 4-12 WEEKS AT QUEST OR LABCORP---THESE ARE PROFOUNDLY THOROUGH. [CASH PAY PATIENTS WITH NO INSURANCE GET A MODEST REDUCED NUMBER OF LABS] ......
A SPECIAL CYTOKINE PANEL DONE AT NATIONAL JEWISH HEALTH...
FINALLY,
I AM STARTING PEOPLE WITH HIGH QUALITY HERBS, MODEST ESSENTIAL OILS AND SEMI-SYNTHETIC HERBS BEFORE TICK OR FLEA INFECTION TESTING....THIS MIGHT CAUSE ANTIBODIES TO BECOME POSITIVE. THIS HAS BEEN SUGGESTED FOR LYME,
BUT IT IS ALSO USEFUL FOR BABESIA [LINDNER, AND ALSO SCHALLER EXPERIENCE--FOR THE RECORD, LINDNER IS MUCH BETTER LOOKING. BUT I AM WORKING ON IT]
THE SAME THING IS FOUND IN BARTONELLA PER PUBLICATION IN WHICH HUMAN ANTIDOIES EMERGED AFTER TREATMENT. THIS IS SEEN IN PUBLICATION BY THE MEDICAL DIRECTOR OF GALAXY LABS WHO IS A KIND MENTOR. [ED BREITSCHWERDT, DVM]
GALAXY IS VERY GOOD AT HELPING DOCTORS PICK THE BEST TEST FOR BLOOG, TISSUE, ETC,
A LITTLE ABOUT ED WHO IS THE LEADING WORLD EXPERT IN BARTONELLA....
Ed Breitschwerdt, DVM; Chief Scientific Officer Galaxy Diagnostics.
Dr. Breitschwerdt is an internist and professor of medicine and infectious diseases at North Carolina State University’s College of Veterinary Medicine. He is a co-director of the Vector Borne Disease Diagnostic Laboratory, which has been testing animals for vector-borne infections since 1984. Importantly, Dr. Breitschwerdt’s research at the NCSU Intracellular Pathogens Research Laboratory has produced significant research findings concerning the medical importance of Bartonella and other emerging infectious disease pathogens in both animal and human health. With over 300 peer-reviewed publications, Dr. Breitschwerdt is an internationally recognized leader in Bartonella research, diagnosis and treatment and has been consulted widely about an array of infectious diseases by many leading companies in the veterinary diagnostics, therapeutics, and vaccine industries. In recognition of his outstanding contributions to research and teaching, Dr. Breitschwerdt has received numbers awards, including the NCSU Holladay Medal for Excellence (2013), AAVMC Excellence in Research Award (2017), the AKC-CHF Canine Health Excellence Award (2018), the WSAVA Global One Health Award (2018), and the Melanie S. Steele Distinguished Professorship in Medicine (2018).